FDA Revokes Janssen COVID-19 Vaccine EUA

At the request of the manufacturer, the FDA revoked the emergency use authorization (EUA) issued to Janssen Biotech, Inc. for its COVID-19 vaccine. In its request letter to the FDA, Janssen indicated that the last lots of the vaccine purchased by the U.S. Government have expired, there is no demand for new lots of this vaccine, and Janssen does not intend to update the strain composition of this vaccine to address emerging variants. Read more.